back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-17 14:58 Tx date 2026-03-13 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
|
+$200,000 vol |
$400,000 | |
| Filed 2026-03-04 20:41 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
|
+$200,000 vol |
$200,000 | |
| Filed 2026-03-04 20:27 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
+$200,000 vol |
||
| Filed 2026-03-04 14:59 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
+$200,000 vol |
||
| Filed 2026-03-04 14:59 Tx date 2026-02-27 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
+$200,000 vol |
$200,000 | |
| Filed 2026-03-04 14:59 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-22 10:54 Tx date 2025-05-21 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
| Filed 2026-01-22 10:52 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-05-21 16:17 Tx date 2025-04-22 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$244,994
+168,104 vol $1.46 each |
7,506,568 | |
| Filed 2025-05-21 16:16 Tx date 2025-04-22 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
-168,104 vol |
1,512,938 | |
| Filed 2025-02-06 13:39 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-15,129,387 vol |
1,681,042 | |
| Filed 2025-02-06 13:33 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-66,046,170 vol |
7,338,464 | |
| Filed 2024-12-18 10:57 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
16,810,429 | ||
| Filed 2024-12-18 10:56 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
73,384,634 |